Last updated 23 days ago

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants with Severe Alopecia Areata

1500 patients around the world
Available in Puerto Rico, Brazil, United States, Chile
AbbVie
10Research sites
1500Patients around the world
This study is for people with
Alopecia
Alopecia areata
Requirements for the patient
To 63 Years
All Gender
Medical requirements
Sites
CIPREC Centro de Investigación y Prevención Cardiovascular - CABA
CIPREC Centro de Investigación y Prevención Cardiovascular - CABA
Recruiting
Av. Pueyrredon 1746, CABA, Buenos Aires
Instituto de Investigaciones Clínicas Córdoba
Instituto de Investigaciones Clínicas Córdoba
Recruiting
Dean Funes 1161, Córdoba
Psoriahue Medicina Interdisciplinaria - CABA, Buenos Aires
Psoriahue Medicina Interdisciplinaria - CABA, Buenos Aires
Recruiting
Bulnes 1937, CABA, Buenos Aires
Centro Médico - Buenos Aires Skin S.A. - CABA, Buenos Aires
Recruiting
Av. Córdoba 1184, CABA, Buenos Aires
Instituto de Neumonología y Dermatología Dr. Luna
Recruiting
Arenales 2557, CABA, Buenos Aires
Hospital Alemão Oswaldo Cruz
Recruiting
R. Treze de Maio, 1815 - Bela Vista, São Paulo - SP, 01323-020, Brazil
Instituto Brasil de Pesquisa Clínica - IBPClin
Recruiting
R. da Glória, 344 - Glória, Rio de Janeiro - RJ, 20241-180
Irmandade da Santa Casa de Misericórdia de Porto Alegre
Recruiting
Rua Professor Annes Dias - Centro Histórico, Porto Alegre - RS, 90020-090, Brazil
Clínica Dermacross S.A. - Vitacura - Santiago
Clínica Dermacross S.A. - Vitacura - Santiago
Recruiting
Av. Manquehue Norte 2051 C, Vitacura, Metropolitana, 7640881
Centro Internacional de Estudios Clínicos - CIEC
Centro Internacional de Estudios Clínicos - CIEC
Recruiting
Calle Manzano 343, Oficina 410-411, Comuna de Recoleta, Región Metropolitana, 8420383
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy